Bioactive Agent and Sensory Experience Combination System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively combine bioactive agents with artificial sensory experiences to alter their effects in a controlled and personalized manner, lacking integration with healthcare systems and individual attributes.
Innovation Solution
A system and method that accepts indications of bioactive agent use and modifies artificial sensory experiences to alter their effects, utilizing circuitry and programming to select and present combinations of prescription medications and artificial sensory experiences based on individual attributes and health data.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bioactive agents are combined with artificial sensory experiences, then treatment efficacy is improved, but system complexity increases
Solution Approach 1:
The system is divided into separate functional modules: a database module for storing bioactive agent information, a selection module for choosing appropriate agents, and a delivery module for administering them. This segmentation allows the complex combination therapy system to be managed through independent, manageable components that can be developed and validated separately.
Solution Approach 2:
A computer system acts as an intermediary between the patient's health data and the bioactive agent selection process. The system receives health data, processes it through algorithms, and generates personalized bioactive agent combinations, thereby managing the complexity of integrating multiple data sources and treatment modalities.
2Measurement precision
If personalized combinations are tailored to individual attributes, then treatment precision is improved, but data processing requirements increase
Solution Approach 1:
Health data and individual attributes are collected and stored in a database before treatment selection occurs. This preliminary data gathering allows the system to quickly retrieve and process relevant information when a bioactive agent combination is needed, reducing real-time data processing requirements while maintaining high treatment precision.
Solution Approach 2:
The system processes multiple health parameters (genetic markers, physiological measurements, lifestyle factors) and transforms them into a standardized format suitable for treatment selection. By changing the parameters into a unified data structure, the system can efficiently process diverse individual attributes without overwhelming data processing requirements.
3Object-affected harmful factors
If side effects are reduced through personalized selection, then patient safety is improved, but selection process complexity increases
Solution Approach 1:
The system incorporates feedback mechanisms that monitor patient responses to bioactive agents and adjust future selections accordingly. By continuously receiving feedback on treatment outcomes and side effects, the system learns to avoid harmful combinations while maintaining effective treatments, thereby reducing side effects through an automated adaptive process rather than manual complex evaluation.
Solution Approach 2:
The system automatically performs the complex task of selecting bioactive agent combinations that minimize side effects, without requiring manual intervention from healthcare providers. The algorithm independently evaluates multiple factors including patient history, genetic markers, and potential interactions, then generates optimized treatment recommendations, freeing clinicians from complex manual selection processes.
Data Source
AI summary
Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or modifying an artificial sensory experience to alter at least one effect of the bioactive agent.